P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 801–900 of 1,000
Altaf, F., Wu, N., Shi, M., Li, J., Shan, J., Su, L. F., Wang, G., Zhu, Q., Hu, Y., Cheng, Y., et al. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.110705 · Cited by 8
Çakır, M. O., Bilge, U., Ghanbari, A., & Ashrafi, G. H. (2023) · Pharmaceuticals · doi:10.3390/ph16121723 · Cited by 7
“The Transcriptional Regulation by TP53 pathway is essential for the control of cell cycle arrest, DNA repair, apoptosis, and senescence [57,58].”
BackgroundA Chromatin-Focused siRNA Screen for Regulators of p53-Dependent Transcription
Sammons, M. A., Zhu, J., & Berger, S. L. (2016) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.031534 · Cited by 5
“…and mediates the expression of cell- and organismal-protective genes involved in processes such as DNA repair, cell cycle arrest, and apoptosis (Kruiswijk et al. 2015). p53 is negatively regulated through direct interaction and ubiquitination by the E3-ubiquitin ligase MDM2, which mediates…”
BackgroundNitrogen Mustard Alkylates and Cross-Links p53 in Human Keratinocytes
Jan, Y.-H., Heck, D. E., An, Y., Laskin, D. L., & Laskin, J. D. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00420 · Cited by 6
Lawal, T. O., Patel, S., & Mahady, G. B. (2023) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v13i7.1105 · Cited by 6
“stimuli including oxidative stress, DNA damage and oncogenic events, that mediate the cell cycle, apoptosis, and autophagy [53-55].”
BackgroundAndreev, D. A., Balakin, E. I., Самойлов, А. С., & Pustovoit, V. I. (2024) · Drug development & registration · doi:10.33380/2305-2066-2024-13-1-1508 · Cited by 6
Monocytes as Targets for Immunomodulation by Regional Citrate Anticoagulation
Marco, G. S. D., Chasan, A. I., Boeckel, G. R., Beul, K., Pavenstädt, H. J., Roth, J., & Brand, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052900 · Cited by 5
“In addition to regulating cell proliferation and apoptosis, p53 controls the expression of many genes involved in cellular metabolism and immunity, playing a protective role in infectious diseases [25–27].”
BackgroundA modular theranostic platform for tumor therapy and its metabolic studies
Li, K., Li, J.-L., Zheng, D., Zeng, X., Liu, C., & Zhang, X. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00231f · Cited by 5
Kudryavtsev, G. Y., Kudryavtseva, L. V., Михалева, Л. М., Kudryavtseva, Y. Y., Solovyeva, N. A., Osipov, V. A., & Бабиченко, И. И. (2020) · RUDN Journal of Medicine · doi:10.22363/2313-0245-2020-24-2-145-155 · Cited by 5
Dafinger, C., Benzing, T. R., Dötsch, J., Schermer, B., & Liebau, M. C. (2021) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-021-00111-1 · Cited by 5
“However, it is wellknown that p53 can regulate cell proliferation, cell survival, and cell death in response to different types of cellular stress in multiple ways [18].”
BackgroundZaher, D. M., Talaat, I. M., Hussein, A., Hachim, M. Y., & Omar, H. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119885 · Cited by 5
Che, J., Su, Z., Yang, W., Xu, L., Li, Y., Wang, H., & Zhou, W. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.05.014 · Cited by 5
Fayed, A. M., Ramadan, H. O., Hassan, S. A., Hussein, M. A., & Roshdy, T. M. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2438 · Cited by 5
Mao, Y., Zong, Z., Dang, Y., Yu, L., Liu, C., & Wang, J. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112673 · Cited by 5
Using machine learning algorithms to identify genes essential for cell survival
Philips, S., Wu, H., & Li, L. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1799-1 · Cited by 5
“…the large scale scanning of PubMed abstracts are involved in the survival pathways and in various malignancies – AKT1 [48 – 50, 53, 58 – 62], TP53 [54, 63, 64], CDH1 [65, 66], CCND1 [67], VEGFA [68, 69], BCL2 [70, 71], ITK [72], CDKN1A [73], EPHB2 [74, 75], BIRC5 [76], MYC [77], EGFR [78, 79],…”
Tumor-suppressive or tumor-supportive: For p53, that is the question
Khan, M. R., Wu, M., & Liu, G. (2018) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1408537 · Cited by 6
Chang, P., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856146 · Cited by 5
From Genome Guardian to Immune Modulator: The Expanding Roles of Tumor Suppressor p53
Wang, W., Liu, J., Feng, Z., & Hu, W. (2025) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2571187 · Cited by 4
“33,34 Interfering with p53 activity in metabolic regulation appears to be a common strategy for intracellular pathogens to survive.”
Rethinking medical education through systems biology to address complexity
David, L., Gourraud, P., Lamirault, G., & Lemarchand, P. (2026) · npj Systems Biology and Applications · doi:10.1038/s41540-025-00636-5 · Cited by 5
“These functions are not hierarchically ordered but emerge as context-dependent outcomes, re fl ecting p53 integration of intracellular signals to balance survival and elimination 57 .”
Lan, A., Li, H., Chen, J., Shen, M., Jin, Y., Dai, Y., Jiang, L., Dai, X., Peng, Y., & Liu, S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13020249 · Cited by 4
“The main reason for the trendy research on p53 is that abnormalities in the p53 signaling pathway are present in almost all human tumors, and mutations in p53 are present in nearly 50% of malignant tumors [10].”
BackgroundCui, X., Liu, C., Dong, P., Liu, C., & Bai, Y. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02445-0 · Cited by 5
“Previous studies also showed that many tumor suppressors regulate ferroptosis and tumors by affecting tumor metabolisms, such as BAP1 and P53 [10, 12, 13].”
BackgroundAday, A. D., Öztan, G., & Süer, İ. (2023) · Experimed · doi:10.26650/experimed.1284215 · Cited by 4
Liu, C., & Zhang, A. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03967-8 · Cited by 4
“As well, p53 is considered as a lifeguard with a license to kill, which has been attributed to its ability to help cell adapt to mild stress and provide a survival advantage, as well as promote cell death or permanently prevent cell proliferation under adverse conditions [32].”
Wada, E., Susumu, N., Kaya, M., & Hayashi, Y. K. (2024) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-024-00915-1 · Cited by 4
“We confirmed that DNA damage and apoptosis were not increased in myotubes from H222P mice, and genes involved in the downstream pathways of DNA damage, such as Trp53 and Atm (Kruiswijk et al. 2015), were expressed at similar levels to those of WT myotubes (Fig.”
Menounos, S., Shen, H. M., Tipirneni, S., & Bhaskar, S. M. M. (2024) · Biomolecules · doi:10.3390/biom14121507 · Cited by 4
Tumour Biology: p53 Gene Mechanisms
Zulfin Shaikh Niranjan, K. C. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000344 · Cited by 4
“Although metabolic activities are integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage [50].”
BackgroundOchwoto, M., Oduma, C. O., Oyugi, J. O., Mwaengo, D. M., Ondigo, B. N., Kimotho, J. H., Maiyo, A. K., Nyangacha, R. M., Chesumbai, G. C., & Songok, E. M. (2019) · F1000Research · doi:10.12688/f1000research.19416.1 · Cited by 4
Artichoke leaf extract and use in metabolic syndrome as an antioxidant
Rezazadeh, K., & Ebrahimi‐Mameghani, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815972-9.00016-0 · Cited by 4
Increased H2O2 levels and p53 stabilization lead to mitochondrial dysfunction in XPC-deficient cells
Freire, T. S., Mori, M. P., Miranda, J. N. F. A., Muta, L. Y. M., Machado, F. T., Moreno, N. C., & de Souza-Pinto, N. C. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab079 · Cited by 5
Fang, X., Shrestha, S. M., Ren, L., & Shi, R. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13297 · Cited by 7
Context dependent roles for RB-E2F transcriptional regulation in tumor suppression
Thwaites, M. J., Cecchini, M. J., Passos, D. T., Zakirova, K., & Dick, F. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0203577 · Cited by 5
The MDM2/MDMX/p53 axis in the adaptive stress response
Wang, B., Rasmussen-Ivey, C. R., Little, J. B., & Yuan, Z.-M. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.89 · Cited by 6
“As a protein extremely responsive to stress, p53 plays a central role in the maintenance of homeostasis by regulating a number of cellular pathways in response to both endogenous and exogenous stress cues (1).”
BackgroundTargeting Tumor Metabolism to Overcome Radioresistance
Wahl, D. R., Petronek, M. S., Rashmi, R., Floberg, J. M., Allen, B. G., & Schwarz, J. K. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_10 · Cited by 5
Miedl, H., Dietrich, B., Kaserer, K., & Schreiber, M. J. (2020) · Cancers · doi:10.3390/cancers12113363 · Cited by 6
Mechanisms of chemoresistance and approaches to overcome its impact in gynecologic cancers
Sabnis, N. A., Mathew, E., Dossou, A. S., Zheng, A., Nagarajan, B., Fudala, R., & Lacko, A. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824299-5.00008-3 · Cited by 8
Model-based optimization of combination protocols for irradiation-insensitive cancers
Hat, B., Jaruszewicz-Błońska, J., & Tomasz Lipniacki, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-69380-6 · Cited by 4
Johnson, E. M., Jayabalan, R., Patra, S. K., & Suh, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.05.539559 · Cited by 4
“323 Activation of the pro-apoptotic TP53 target such as BAX, FAS, BBC3 require the presence of the 324 complex between TP53 and ASPP protein either ASPP1 or ASPP2, depending on which the 325 interaction with the specific co-factors modulates the cellular response/outcome (29).”
BackgroundProteomics and metabolomics in cancer biomarker discovery
Basoya, R., Bhasin, N., Jain, P., & Aggarwal, S. (2025) · Methods in cell biology · doi:10.1016/bs.mcb.2025.02.010 · Cited by 3
Sun, J., Liu, K., Yao, S., Zhang, H., Wang, J., Wang, Y., Tian, R., Xi, Z., Tian, S., Wang, P., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.09.009 · Cited by 4
Yan, X., Xu, W., Yao, H., Wu, Z., Ning, J., Zhao, S., Liu, Y., Zhang, M., Xu, D., Shen, Z., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0649 · Cited by 6
Li, R., Yang, W., Zheng, L., Yan, X., Liu, C., Zhang, Y., & Li, J. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117684 · Cited by 3
Montellier, E., Manches, O., Gaucher, J., Freyçon, C., Hoyos, D. B. C., Blanchet, S., Verboom, M., Dutzmann, C. M., Coutant, S., Bou, J., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.106065 · Cited by 4
Autophagy–Apoptosis Crosstalk in Cancer: Mechanisms, Signaling Pathways, and Therapeutic Targeting
Kakkar, D., Saxena, S., Dhawan, U., Dosi, N., Khanna, C., & Paul, S. (2026) · Cancers · doi:10.3390/cancers18101564 · Cited by 4
Wu, Y., Song, L., Kong, J., Qian, W., Jiao, J., Wang, X., Li, G., Xu, X. D., & Zhan, L. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166823 · Cited by 3
Camblor‐Perujo, S., Ozer, E., Küpper, H., Overhoff, M., Rastogi, S., Bazzi, H., & Kononenko, N. L. (2023) · Life Science Alliance · doi:10.26508/lsa.202302029 · Cited by 4
“…cell death and cell differentiation in these cells, but the mechanisms may be related in part to the p53 signaling axis, which can trigger either the cell elimination or cell survival program depending on cell type and persistence of DNA damage (Murray-Zmijewski et al, 2008; Kruiswijk et al, 2015).”
BackgroundYahya, T. S. A. N. T., Azmi, N. C., Yee, F. S., Chyang, P. J., Ng, S. T., & Tan, C.-S. (2024) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushrooms.2024052325 · Cited by 3
Mina53 catalyzes arginine demethylation of p53 to promote tumor growth
Zhou, L., Yu, L., Song, S., Wang, Y., Zhu, Q., Li, M., Sha, Y., Xu, L., Shu, X., Liao, Q., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115242 · Cited by 4
p53-dependent chromatin relaxation is required for DNA double-strand break repair
Chen, H., Shan, J., Qi, W., Chen, L., & Zeng, X. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025008 · Cited by 9
“…to MDM2, resulting in an increase in p53 in cells [18]. p53 plays a pivotal role in the response to cellular stress and can control the transcription of hundreds of genes involved in several biological functions, such as DNA damage repair, cell cycle arrest, apoptosis, and senescence [19,20].”
Mustafa, M., & Gharaibeh, M. A. (2022) · The Protein Journal · doi:10.1007/s10930-022-10041-0 · Cited by 3
“The p53 protein functions primarily as a transcription factor that can either activate or repress the expression of a large number of DNAs and microRNAs [5, 6] and as a mediator for integrating appropriate cellular signals via protein–protein and protein–DNA interactions [7].”
BackgroundDjordjevic, S., Itzykson, R., Hague, F., Lebon, D., Legrand, J., Ouled‐Haddou, H., Jedraszak, G., Harbonnier, J., Collet, L., Paubelle, É., et al. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13584 · Cited by 3
Prediction of traditional Chinese medicine for diabetes based on the multi-source ensemble method
Yang, B., Chi, Q., Li, X., & Wang, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1454029 · Cited by 4
Pyruvate Carboxylase as a Moonlighting Metabolic Enzyme Protects β‐Cell From Senescence
Yang, Y., Wang, B., & Li, X. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70050 · Cited by 3
Paradoxical Puma Prohibits Pyruvate Pumps to Prime Pathology
Green, D. R. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.016 · Cited by 3
The RB gene family controls the maturation state of the EndoC-βH2 human pancreatic β-cells
Maugein, A., Diedisheim, M., Bailly, K., Scharfmann, R., & Albagli, O. (2020) · Differentiation · doi:10.1016/j.diff.2020.02.001 · Cited by 3
Bizzarri, A. R., & Cannistraro, S. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c06778 · Cited by 3
(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac132.178 · Cited by 3
“The increase in p53 level causes either cell cycle arrest or apoptosis, both of which inhibit tumor growth.[35]Bcl-2 is an anti-apoptotic protein (proliferative protein) that inhibits cell death and apoptosis.”
BackgroundAlhaithloul, H. A. S., Abdein, M. A. E.-H., & Awad, N. S. (2022) · Ecology Environment and Conservation · doi:10.53550/eec.2022.v28i01s.081 · Cited by 3
Lee, H., Kim, T.-H., & Yoo, J.-Y. (2023) · Journal of Cell Science · doi:10.1242/jcs.260593 · Cited by 3
Codon 249 P53 Gene Mutation Among Hepatocellular Carcinoma Patients in Western Kenya
Colins, O. D. (2020) · Open Access Journal of Biomedical Science · doi:10.38125/oajbs.000136 · Cited by 3
“This it does through (i) preventing the replication of damaged DNA while activating the transcription of proteins taking part in DNA repair and (ii) triggering the cell to induce apoptosis, cell cycle arrest or senescence in the event the damage is severe and cannot be repaired [3,4] .”
BackgroundA novel function of CYP21A2 in regulating cell migration and invasion via Wnt signaling
Guo, Y., Rehati, A., Wu, Z., Zhang, W., Zhuang, P., & He, F. (2020) · General Physiology and Biophysics · doi:10.4149/gpb_2020004 · Cited by 4
“The tumor suppressor p53 is a well known transcription factor involved in cancer (Kruiswijk et al. 2015).”
BackgroundP53 and DNA Methylation in the Aging Process
Wang, Y., & Shi, J. (2021) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2021.114007 · Cited by 3
“The P53 signaling pathway plays an important role in many aspects, such as cell cycle regulation, development, reproduction, metabolism, senescence, tumor inhibition, etc. [16] [17].”
Cellular and Molecular Mechanisms of Tumor Promotion
Bode, A. M., & Zhang, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00059-0 · Cited by 3
ARHGAP11A is a potential prognostic biomarker and therapeutic target for pancreatic adenocarcinoma
Shu, Q.-A., Huang, X., Wu, J., Liang, X.-R., Wang, Y., Yu, J., Wang, Z., Liu, N., Wang, J., & Xie, N. (2025) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2025.106804 · Cited by 3
Xia, L., Lei, X., Zhou, L., Liu, X., Lin, P., Hou, T., Xu, H., Su, S., Li, Y., Chen, C., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115396 · Cited by 4
Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug design
Ricci, D., Menditto, M., Culletta, G., Tutone, M., Rizzo, C., Pace, A., Lentini, L., & Pibiri, I. (2026) · Scientific Reports · doi:10.1038/s41598-026-48790-y · Cited by 2
“It also regulates ferroptosis, glycolysis, oxidative phosphorylation, fatty acid metabolism, immune responses and ageing 13,14 (Fig.”
p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program
Wang, M., Bieging-Rolett, K. T., Kaiser, A. M., Brady, C. A., Lockhart, J. H., Ferreira, S., Nguyen, K. T., Rajeevan, A., Evans, S. A., Zhao, T., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0525 · Cited by 5
Metadichol Orchestrates T, B, and NK Cell Immunity Through Master Regulator Gene Networks
Raghavan, P. R. (2026) · Medical Research Archives · doi:10.18103/mra.2026.0422 · Cited by 2
Dichotomous Impact of Myc on rRNA Gene Activation and Silencing in B Cell Lymphomagenesis
Joshi, G., Eberhardt, A. O., Lange, L. D., Winkler, R., Hoffmann, S., Kosan, C., & Bierhoff, H. (2020) · Cancers · doi:10.3390/cancers12103009 · Cited by 3
“To further characterize the underlying death pathway, we monitored DNA damage-induced up-regulation of p53 [43,44].”
BackgroundCui, Q., Wu, H., Zeng, W., Du, H., Xiao, Z., Hou, T., Li, M., Li, Y., Zhang, Z., & Li, Z. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-5908 · Cited by 2
“The p53 signaling pathway has been well-documented to contribute in cell cycle regulation, metabolism, aging and development, reproduction, suppression of tumor expression, and so on (59-61).”
BackgroundThe Relationship of Gliomas with Tp53 Rs1042522 C > G And Gliomas in Duhok
Nerweyi, F. F. A. (2020) · The Journal of The University of Duhok · doi:10.26682/sjuod.2020.23.2.16 · Cited by 2
“P53 has been shown to play an important role in controlling the cell cycle, cell formation, differentiation, proliferation and apoptosis as a 53 kDa protein encoded by the TP53 gene (Kruiswijk et al., 2015).”
BackgroundDriverMP enables improved identification of cancer driver genes
Liu, Y., Han, J., Kong, T., Xiao, N., Mei, Q., & Liu, J. (2022) · GigaScience · doi:10.1093/gigascience/giad106 · Cited by 2
“Under stress conditions, it regulates the transcription of many genes involved in v arious cellular pr ocesses, suc h as cellular metabolism, surviv al, senescence , apoptosis , and the DNA damage response [ 54 ].”
Huo, H., Feng, Y., & Tang, Q. (2024) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2024.101971 · Cited by 2
Sun, R., Li, S., Ye, W., & Lü, Y. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03586-w · Cited by 2
“Recognized as a tumor inhibitor gene, TP53 plays a pivotal role in orchestrating a spectrum of cellular activities like regulating cell cycle, DNA restitution, programmed cell death, and metabolic processes [66, 67].”
Exploring the therapeutic role of carnosol in cancer: from molecular insights to clinical promise
Nakhaei, A., Afshari, S., Omidkhoda, A., Mohtashami, E., Vahedi, M. M., Ahmadi, S. S., Jalali, M., & Afshari, A. R. (2025) · Medical Oncology · doi:10.1007/s12032-025-02959-z · Cited by 3
The potential functions of ferroptosis on urinary stones: mechanisms and therapeutic implications
Ran, Y., Ma, Y., Luo, Y., & Ruan, Y. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1633468 · Cited by 4
“The tumor suppressor p53 serves as a master regulator of diverse cellular processes, including cell survival, apoptosis and DNA repair (Kruiswijk et al., 2015; Green and Kroemer, 2009; Levine, 2019).”
Cao, J., Tsao, R., Yang, C., Wang, Y., & Zhang, L. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107628 · Cited by 2
Zaatra, W., Philippos, G., Smirnov, P., Milo, S., Otoničar, J., Chan, M., Harel, M., Devens, F., Goldberg, T., Eliassaf, A., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.08.003 · Cited by 2
Wu, G., Wang, W., Liu, Y., Zhuang, K., Cai, T., Wang, Z. F., & Yang, L. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.076 · Cited by 2
RetractedNuti, E., Pietra, V. L., Daniele, S., Cuffaro, D., Ciccone, L., Giacomelli, C., Cason, C., Carotenuto, A., D’Amore, V. M., Pozzo, E. D., et al. (2022) · Pharmaceuticals · doi:10.3390/ph15111318 · Cited by 3
Jiang, J., Qiu, T., Yang, C., Yuan, Y., Qin, L., & Zhang, P. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11979 · Cited by 2
“We thus considered more physiological signaling pathways that can mildly activate p53 (Kruiswijk et al., 2015).”
BackgroundActivation of P53 pathway contributes to Xenopus hybrid inviability
Shi, Z., Liu, G., Jiang, H., Shi, S., Zhang, X., Deng, Y., & Chen, Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303698120 · Cited by 3
“P53 is known to regulate various metabolic pathways and can act as a metabolic sensor (25, 26).”
P53, ROS: Redox Regulation Signaling, Metabolic Reprogramming, and Autophagy in Cancer
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_7 · Cited by 3
HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers
Di-Iacovo, N., Ferracchiato, S., Pieroni, S., Scopetti, D., Castelli, M., Piobbico, D., Pierucci, L., Gargaro, M., Chiasserini, D., Servillo, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094600 · Cited by 2
“Indeed, other vital homeostatic cell programs, antioxidant stress, autophagy, and metabolism regulation have been ascribed to p53 [6–8].”
Backgroundp53 REEPs to sow ER–mitochondrial contacts
Bock, F. J., & Tait, S. W. G. (2018) · Cell Research · doi:10.1038/s41422-018-0073-z · Cited by 2
Hassannia, B., & Berghe, T. V. (2019) · Springer eBooks · doi:10.1007/978-3-030-26780-3_17 · Cited by 4
Campos, A. M. O., Pereira, R., Vaz, A. M. N., Caetano, T., Malta, M., Oliveira, J. M., Carvalho, F. P., Mendo, S., & Lourenço, J. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122634 · Cited by 2
Khare, V. M., SAXENA, V. K., Pasternak, M. A., Nyinawabera, A., Singh, K. B., Ashby, C. R., Tiwari, A. K., & Tang, Y. (2021) · Genes and Immunity · doi:10.1038/s41435-021-00158-0 · Cited by 2
“The p53 protein, encoded by TP53, has a significant impact on the innate immune response due to its tumor-suppressor efficacy [28].”
BackgroundWang, J., Ding, Z., Shu, W., & Zhuge, Y. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110728 · Cited by 2
TRAIL-R deficient mice are protected from neurotoxic effects of amyloid-βPreprint
Benedetto, G. D., Burgaletto, C., Serapide, M. F., Caltabiano, R., Munafò, A., Bellanca, C. M., Mauro, R. D., Bernardini, R., & Cantarella, G. (2022) · Research Square · doi:10.21203/rs.3.rs-1124682/v2 · Cited by 2
Abramenko, I. V., Bilous, N. I., Aa, C., Dyagil, I., & Martina, Z. (2021) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-43-no-3.16474 · Cited by 1
1H, 15N and 13C backbone resonance assignments of the acidic domain of the human MDM2 protein
Song, Q., Liu, X., & Rainey, J. K. (2022) · Biomolecular NMR Assignments · doi:10.1007/s12104-022-10112-4 · Cited by 1
“Namely, p53 facilitates DNA damage repair, triggering cell cycle arrest or senescence, ultimately stimulating apoptosis when cellular damage is irreparable (Kruiswijk et al. 2015).”
BackgroundLi, D., Lei, L., Wang, J., Tang, B., Wang, J., Dong, R., Shi, W., Liu, G., Zhao, T., Wu, Y., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1075347 · Cited by 1
“WTp53 promotes OXPHOS and inhibits glycolysis by regulating the expression or activity of metabolic enzymes, thus enabling the tumor inhibitory activity of p53 by disrupting cancer metabolism (Kruiswijk et al., 2015).”
BackgroundROS, Redox Regulation and Signaling in Cancer Cells
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_1 · Cited by 4
Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53‐deficient myeloma cells
Durand, R., Bellanger, C., Descamps, G., Dousset, C., Maïga, S., Derrien, J., Thirouard, L., Bouard, L., Asnagli, H., Beer, P. A., et al. (2024) · HemaSphere · doi:10.1002/hem3.70016 · Cited by 2
“9 – 11 p53 ‐ deficient cells also lose p53 ‐ mediated cell cycle checkpoints, but retain the S/G2 checkpoints, which was recently shown to be controlled by ATR.”
BackgroundMignon, J., Leyder, T., & Michaux, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21809-5.00011-9 · Cited by 1
Mitochondrial Oncology: Present Insights and Future Perspectives
Palacka, P., & Singh, K. K. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-75741-9_12 · Cited by 1
Deletion of a novel upstream promoter of p53 impairs cold tolerance capacity in zebrafish
Li, W., Song, H., Cai, X., Wang, Y., Zhang, Y., Sun, C., Zhang, J., & Zhang, J. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151969 · Cited by 1
Yu, J.-C., Hsieh, B. Y., Tsai, S., & Hsieh, M. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70081 · Cited by 1
“It is well ‐ established that p53 can inhibit glycolysis by repressing the expression of multiple glycolytic enzyme genes and/or by increasing expression of TP53 ‑ inducible glycolysis and apoptosis regulator (TIGAR) [35, 50].”
Toth, A. R., Lakat, T., Budai, A., Kallay, H., Szokol, B., Wagner, L. J., Őrfi, L., Krekó, M., Szabo, A. J., Fekete, A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-23459-0 · Cited by 1
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.